Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

H2020

EbolaVac

Project reference: 666085
Funded under

Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine

From 2014-10-07 to 2017-10-06, ongoing project

Project details

Total cost:

EUR 22 055 090,88

EU contribution:

EUR 15 153 216

Coordinated in:

Belgium

Topic(s):

Health - Health

Call for proposal:

H2020-Adhoc-2014-20See other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Related information

Open Access

Coordinator

GlaxoSmithKline Biologicals S.A
Belgium

EU contribution: EUR 14 103 135


Rue de l’Institut
1330 Rixensart
Belgium

Participants

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 942 581


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Germany

EU contribution: EUR 107 500


BERNHARD NOCHT STRASSE 74
20359 HAMBURG
Germany
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
Switzerland

EU contribution: EUR 0


RUE DU BUGNON 21
1005 LAUSANNE
Switzerland
Record Number: 196375 / Last updated on: 2016-07-04